Integrating AI-Guided Design with Experimental Validation for Niosome-Based Drug Delivery Systems

To develop and experimentally validate an explainable artificial intelligence (AI) framework that extracts formulation rules for niosomal drug delivery systems from published data and delivers them through a decision-support platform. Niosome performance depends on many interacting formulation and process variables, and optimization still relies largely on trial-and-error experimentation. Converting existing formulation knowledge into interpretable, experimentally verified rules could make early-stage development faster and less resource-intensive. A database of 33 optimized niosomal formulations (approximately 30 drugs, BCS classes I–V) was compiled from peer-reviewed studies. Correlation analysis, XGBoost feature importance, and SHAP were used to relate formulation variables to particle size, entrapment efficiency (EE%), drug release, and release time. The extracted trends were tested experimentally using 17 diclofenac sodium-loaded niosomal formulations prepared by thin-film hydration. The dataset was expanded to 1000 samples using SMOTE to train XGBoost predictive models, which were evaluated on the original formulations and integrated with a Qwen-based large language model. Phosphate-buffered saline as the hydration medium, Span 60, and chloroform volume were the most influential variables. Laboratory results agreed with the AI-predicted direction of effect for all tested variables: cholesterol, Span 60, chloroform volume, Tween 80, and hydration medium. The predictive models achieved R2 values of 0.97–0.99 on the original formulations, and the resulting Niosome AI Expert platform showed general agreement between predicted and reported outcomes. Combining machine learning, explainable AI, and experimental verification can convert existing formulation knowledge into a practical decision-support tool that reduces reliance on trial-and-error niosome development.

Authors

Publication Details

Journal
Figshare
Published
2026-11-17
DOI
https://doi.org/10.6084/m9.figshare.35039658
Primary Topic
Advanced Drug Delivery Systems
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Integrating AI-Guided Design with Experimental Validation for Niosome-Based Drug Delivery Systems

Yasmein Yaser Salem, Hamzah Dabool, Tasneem Zarzour, Rana Sammour et al.
2 links
Figshare
Advanced Drug Delivery Systems
article

Integrating AI-Guided Design with Experimental Validation for Niosome-Based Drug Delivery Systems

Yasmein Yaser Salem, Hamzah Dabool, Tasneem Zarzour, Rana Sammour, Joud Hourani, Sara Abdelgawwad, Ranim Al Rfai
article en

Abstract

To develop and experimentally validate an explainable artificial intelligence (AI) framework that extracts formulation rules for niosomal drug delivery systems from published data and delivers them through a decision-support platform. Niosome performance depends on many interacting formulation and process variables, and optimization still relies largely on trial-and-error experimentation. Converting existing formulation knowledge into interpretable, experimentally verified rules could make early-stage development faster and less resource-intensive. A database of 33 optimized niosomal formulations (approximately 30 drugs, BCS classes I–V) was compiled from peer-reviewed studies. Correlation analysis, XGBoost feature importance, and SHAP were used to relate formulation variables to particle size, entrapment efficiency (EE%), drug release, and release time. The extracted trends were tested experimentally using 17 diclofenac sodium-loaded niosomal formulations prepared by thin-film hydration. The dataset was expanded to 1000 samples using SMOTE to train XGBoost predictive models, which were evaluated on the original formulations and integrated with a Qwen-based large language model. Phosphate-buffered saline as the hydration medium, Span 60, and chloroform volume were the most influential variables. Laboratory results agreed with the AI-predicted direction of effect for all tested variables: cholesterol, Span 60, chloroform volume, Tween 80, and hydration medium. The predictive models achieved R2 values of 0.97–0.99 on the original formulations, and the resulting Niosome AI Expert platform showed general agreement between predicted and reported outcomes. Combining machine learning, explainable AI, and experimental verification can convert existing formulation knowledge into a practical decision-support tool that reduces reliance on trial-and-error niosome development.

Figshare
Good health and well-being
Advanced Drug Delivery Systems
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon